nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute graft versus host disease after orthotopic liver transplantation
|
Rogulj, Inga Mandac |
|
2012 |
5 |
1 |
|
artikel |
2 |
Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia
|
Chen, Huan |
|
2012 |
5 |
1 |
|
artikel |
3 |
Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
|
Lv, Meng |
|
2012 |
5 |
1 |
|
artikel |
4 |
Alterations in the ribosomal machinery in cancer and hematologic disorders
|
Shenoy, Niraj |
|
2012 |
5 |
1 |
|
artikel |
5 |
Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia
|
Li, Bo |
|
2012 |
5 |
1 |
|
artikel |
6 |
Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia
|
Zha, Xianfeng |
|
2012 |
5 |
1 |
|
artikel |
7 |
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
|
Sun, Weijing |
|
2012 |
5 |
1 |
|
artikel |
8 |
A novel monoclonal antibody of human stem cell factor inhibits umbilical cord blood stem cell ex vivo expansion
|
Fan, Jie |
|
2012 |
5 |
1 |
|
artikel |
9 |
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
|
Wang, Eunice S |
|
2012 |
5 |
1 |
|
artikel |
10 |
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
|
Galimberti, Sara |
|
2012 |
5 |
1 |
|
artikel |
11 |
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
|
Li, Ning |
|
2012 |
5 |
1 |
|
artikel |
12 |
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
|
Zinzani, Pier Luigi |
|
2012 |
5 |
1 |
|
artikel |
13 |
Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors ? -- A literature-based meta-analysis
|
Xu, Chongrui |
|
2012 |
5 |
1 |
|
artikel |
14 |
Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
|
Huang, Xuan |
|
2012 |
5 |
1 |
|
artikel |
15 |
Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients
|
Wang, Yan-Fang |
|
2012 |
5 |
1 |
|
artikel |
16 |
Clinical applications of mesenchymal stem cells
|
Wang, Shihua |
|
2012 |
5 |
1 |
|
artikel |
17 |
Comparative mitochondrial proteomics: perspective in human diseases
|
Jiang, Yujie |
|
2012 |
5 |
1 |
|
artikel |
18 |
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
|
Chauchet, Adrien |
|
2012 |
5 |
1 |
|
artikel |
19 |
Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
|
Zou, Limin |
|
2012 |
5 |
1 |
|
artikel |
20 |
Current management and novel agents for malignant melanoma
|
Lee, Byung |
|
2012 |
5 |
1 |
|
artikel |
21 |
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide
|
Sugimoto, Yuka |
|
2012 |
5 |
1 |
|
artikel |
22 |
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
|
Predina, Jarrod D |
|
2012 |
5 |
1 |
|
artikel |
23 |
Deprivation of arginine by recombinant human arginase in prostate cancer cells
|
Hsueh, Eddy C |
|
2012 |
5 |
1 |
|
artikel |
24 |
Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis
|
Tognon, Raquel |
|
2012 |
5 |
1 |
|
artikel |
25 |
Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols
|
Greaves, Wesley |
|
2012 |
5 |
1 |
|
artikel |
26 |
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
|
Hemminki, Kari |
|
2012 |
5 |
1 |
|
artikel |
27 |
Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia
|
Zou, Yong |
|
2012 |
5 |
1 |
|
artikel |
28 |
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
|
Xuan, Li |
|
2012 |
5 |
1 |
|
artikel |
29 |
EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
|
Yang, Zu-Yao |
|
2012 |
5 |
1 |
|
artikel |
30 |
Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF
|
Roy, Sanchita |
|
2012 |
5 |
1 |
|
artikel |
31 |
Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity
|
Chen, Yun |
|
2012 |
5 |
1 |
|
artikel |
32 |
Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large b-cell lymphoma: a review of the literature
|
Tirado, Carlos A |
|
2012 |
5 |
1 |
|
artikel |
33 |
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
|
Sosin, Angela M |
|
2012 |
5 |
1 |
|
artikel |
34 |
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis
|
Guo, Yantong |
|
2012 |
5 |
1 |
|
artikel |
35 |
Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
|
Jin, Xuan |
|
2012 |
5 |
1 |
|
artikel |
36 |
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
|
Chang, David Z |
|
2012 |
5 |
1 |
|
artikel |
37 |
MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling
|
Virtue, Anthony |
|
2012 |
5 |
1 |
|
artikel |
38 |
MicroRNAs in B cell development and malignancy
|
Fernando, Thilini R |
|
2012 |
5 |
1 |
|
artikel |
39 |
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
|
Faraoni, Isabella |
|
2012 |
5 |
1 |
|
artikel |
40 |
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
|
Chotirat, Sadudee |
|
2012 |
5 |
1 |
|
artikel |
41 |
Molecular functions of metallothionein and its role in hematological malignancies
|
Takahashi, Shinichiro |
|
2012 |
5 |
1 |
|
artikel |
42 |
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
|
Rachagani, Satyanarayana |
|
2012 |
5 |
1 |
|
artikel |
43 |
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
|
Gelsi-Boyer, Véronique |
|
2012 |
5 |
1 |
|
artikel |
44 |
Novel CD20 monoclonal antibodies for lymphoma therapy
|
Cang, Shundong |
|
2012 |
5 |
1 |
|
artikel |
45 |
Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases
|
Imajoh, Masayuki |
|
2012 |
5 |
1 |
|
artikel |
46 |
Novel targeted agents for gastric cancer
|
Liu, Lian |
|
2012 |
5 |
1 |
|
artikel |
47 |
Novel therapeutic agents for cutaneous T-Cell lymphoma
|
Jain, Salvia |
|
2012 |
5 |
1 |
|
artikel |
48 |
Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells
|
Hu, Chaoquan |
|
2012 |
5 |
1 |
|
artikel |
49 |
Outcome of therapy-related myeloid neoplasms treated with azacitidine
|
Fianchi, Luana |
|
2012 |
5 |
1 |
|
artikel |
50 |
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
|
Li, Jie |
|
2012 |
5 |
1 |
|
artikel |
51 |
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma
|
Ponti, Giovanni |
|
2012 |
5 |
1 |
|
artikel |
52 |
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
|
Takahashi, Naoto |
|
2012 |
5 |
1 |
|
artikel |
53 |
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
|
Raza, Azra |
|
2012 |
5 |
1 |
|
artikel |
54 |
Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
|
Galili, Naomi |
|
2012 |
5 |
1 |
|
artikel |
55 |
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
|
Kim, Yu Ri |
|
2012 |
5 |
1 |
|
artikel |
56 |
Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
|
Guimarães, Cristina |
|
2012 |
5 |
1 |
|
artikel |
57 |
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
|
Lamba, Gurpreet |
|
2012 |
5 |
1 |
|
artikel |
58 |
Recent updates on the role of microRNAs in prostate cancer
|
Hassan, Oudai |
|
2012 |
5 |
1 |
|
artikel |
59 |
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
|
McBride, Ali |
|
2012 |
5 |
1 |
|
artikel |
60 |
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
|
Vincenzi, Bruno |
|
2012 |
5 |
1 |
|
artikel |
61 |
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia
|
Albano, Francesco |
|
2012 |
5 |
1 |
|
artikel |
62 |
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
|
Iriyama, Noriyoshi |
|
2012 |
5 |
1 |
|
artikel |
63 |
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
|
Randhawa, Jasleen |
|
2012 |
5 |
1 |
|
artikel |
64 |
Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment
|
Hong, Kyung Taek |
|
2012 |
5 |
1 |
|
artikel |
65 |
SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells
|
Guo, Yao |
|
2012 |
5 |
1 |
|
artikel |
66 |
Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization
|
Wang, Wen-Quan |
|
2012 |
5 |
1 |
|
artikel |
67 |
Targeted drug delivery for cancer therapy: the other side of antibodies
|
Firer, Michael A |
|
2012 |
5 |
1 |
|
artikel |
68 |
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
|
Labbaye, Catherine |
|
2012 |
5 |
1 |
|
artikel |
69 |
The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells
|
Halsey, Christina |
|
2012 |
5 |
1 |
|
artikel |
70 |
Therapeutic advancement of chronic lymphocytic leukemia
|
Lu, Kang |
|
2012 |
5 |
1 |
|
artikel |
71 |
The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
|
Zhang, Li-Juan |
|
2012 |
5 |
1 |
|
artikel |
72 |
The significance of low PU.1 expression in patients with acute promyelocytic leukemia
|
Zhu, Xuehua |
|
2012 |
5 |
1 |
|
artikel |
73 |
The unfolded von Willebrand factor response in bloodstream: the self-association perspective
|
Yuan, Hailong |
|
2012 |
5 |
1 |
|
artikel |
74 |
Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients
|
de Castro, Cláudio César Monteiro |
|
2012 |
5 |
1 |
|
artikel |
75 |
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
|
Chim, Chor Sang |
|
2012 |
5 |
1 |
|
artikel |